Moderna | MRNA - Operating Profit


Moderna reported $-815M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Acadia Pharmaceuticals USD 37.84M 42.45M Jun/2026
Agios Pharmaceuticals USD -110.02M 11.55M Mar/2026
Alnylam Pharmaceuticals USD 112.6M 24.99M Jun/2026
Amgen USD 4.61B 777M Jun/2026
Arrowhead Research USD -170.09M 28.83M Jun/2026
Biogen USD -243.8M 758.1M Jun/2026
BioMarin Pharmaceutical USD 105.6M 24.04M Jun/2026
Celltrion KRW 12.9B 822.77M Mar/2026
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Deva Holding AS TRY 964.87M 240.32M Sep/2023
Dianthus Therapeutics USD -46.53M 23.01M Mar/2026
Divis Laboratories Ltd INR 11.29B 3.15B Jun/2026
Gilead Sciences USD 3.85B 1.17B Jun/2026
GlaxoSmithKline GBP 2.6B 312M Jun/2026
Incyte USD 700.4M 376.22M Jun/2026
Ionis Pharmaceuticals USD -102.29M 15.71M Jun/2026
Kangmei Pharma CNY -35.26M 24.32M Jun/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Malin Corporation EUR -1.1M 400K Dec/2024
Moderna USD -815M 573M Jun/2026
Organigram Holdings CAD -9.79M 10.33M Mar/2026
Ovoca Bio EUR -173K 990K Dec/2025
Pharma Mar EUR -1.4M 2.03M Jun/2026
Puma Biotechnology USD 22.08M 24.26M Sep/2024
Qiagen NV USD 141.4M 24.77M Jun/2026
Regeneron Pharmaceuticals USD 1.42B 675.7M Jun/2026
Sangamo BioSciences USD -33.51M 12.77M Jun/2024
Sarepta Therapeutics USD 13.29M 345.14M Jun/2026
Sartorius EUR 164M 3.3M Jun/2026
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Tilray USD -20.01M 9.34M Sep/2025
Ultragenyx Pharmaceutical USD -75M 141M Jun/2026
United Therapeutics USD 330.8M 5M Jun/2026
Vertex Pharmaceuticals USD 1.27B 129.9M Jun/2026
Zealand Pharma A/S -539M 168.05M Mar/2026
Zz Pientze Pharmaceu CNY 362.83M 474.98M Jun/2026